Agoracom Blog Home

Posts Tagged ‘tsx’

CLIENT FEATURE: Eyecarrot Innovations $EYC.ca Creating Faster Brains Through Stronger Eyes $EYPT $KALA

Posted by AGORACOM-JC at 5:54 PM on Tuesday, June 2nd, 2020
http://www.smallcapepicenter.com/eyc%20square.png

EYC: TSX-V

Trusted and used by some of the world’s top professional sports teams, including:

Why Eyecarrot?

  • Eyecarrot Has Already Started Commercializing Its Vision Therapy Platform
  • Company’s Vision Therapy Products Used In:
    • Over 1,500 Practices
    • 20 Countries
  • Flagship “Binovi” Is State-Of-The-Art Platform
    • Measures 14 Key Vision Skills
    • Essential For Maximizing Brain Performance
    • Shipped Over 400 Binovi Units (April 2020)
    • Goal Is 2,500 Binovi Units (End Of 2020)
  • Signed Sports Vision Partnership With Eli Wilson Goaltending
    • World Leader In Goaltending Development
    • 600 Active Goaltending Camp Participants
    • 50,000 Global Aspiring Goaltenders
  • Closed Major Financing In Q1 2020
  • Eyecarrot is now well positioned to further commercialize and capitalize on massive demand for Vision Therapy and Training For Athletes and Education

Serial Entreprenuer and Former Aurora Cannabis CEO, Terry Booth, Joins Eyecarrot as Executive Chairman

  • Mr. Booth was one of the 2 original founders of Aurora Cannabis Inc. In 2013, he personally provided over $3.0 million in start-up capital to the building of a new from the ground up high quality purpose-built medical cannabis production facility in Mountain View County.
  • Appointed CEO in December 2014, he has skillfully raised Aurora from its infancy into one of the world’s largest and fastest growing cannabis companies, valued at $18B at its peak

THE MARKET OPPORTUNITY

  • Vision Therapy captures 3% of a $36B Yearly Vision Market today
  • Vision Therapy will grow by 22% this year and account for 4% of the $39B Yearly Market by year end
  • Sights are set on disrupting the sports performance industry in 2020 while receiving engagement from leaders within the human performance – sport performance industry
  • The size of the sports performance market reached a value of nearly $488.5B in 2018, having grown at a compound annual growth rate (CAGR) of 4.3% since 2014
  • Expected to grow at a CAGR of 5.9% to nearly $614.1B by 2022

WATCH OUR RECENT INTERVIEW

Eyecarrot Innovations is an advertising client of AGORA Internet Relations Corp.

Primo Nutraceuticals Inc. $PRMO.ca Receives Approval to Sell its Hand Sanitizer on #Amazon.com $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 9:20 AM on Tuesday, June 2nd, 2020
  • Announced that it has received approval from Amazon to sell their Primo Lemon Hand Sanitizer in Amazon’s Personal Safety & Household category
  • Through continued perseverance and multiple discussions with customer care, and due to Primo meeting all the required criteria as a licensed establishment with a product that has been licensed and approved by Health Canada, Primo was finally granted permission from Amazon to sell its hand sanitizer on their website.

VANCOUVER, British Columbia, June 02, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has received approval from Amazon to sell their Primo Lemon Hand Sanitizer in Amazon’s Personal Safety & Household category.

In response to the increasing demand for hand sanitizers in Canada, approximately two months ago Primo filled out an online application to sell its hand sanitizer on Amazon. Primo was granted a Seller Central account but was initially denied the ability to list its hand sanitizer, as Amazon was no longer approving new listings in this category. In early March, Amazon began restricting the types of sellers on its third-party Marketplace platform that are able to sell health and sanitation products, such as: face masks, hand sanitizer, disinfecting wipes/ sprays, isopropyl alcohol, among other products. 

Through continued perseverance and multiple discussions with customer care, and due to Primo meeting all the required criteria as a licensed establishment with a product that has been licensed and approved by Health Canada, Primo was finally granted permission from Amazon to sell its hand sanitizer on their website.

The approval by Amazon could not have come at a better time for the company as its first shipment of hand sanitizer was picked up at their manufacturer on Friday, May 29th, 2020 with an expected delivery of later this week.

In reference to the company’s press release dated March 24th, Primo will be handing out the hand sanitizer as well as promotional samples for procurement departments in the healthcare industry across Canada to essential workers.

The company will also be taking the opportunity to hand out samples to potential customers that are interested in purchasing the hand sanitizer in bulk orders.

To view the product brochure, please visit: https://www.primoceuticals.com/shop#!/Primo-Lemon-Hand-Sanitizer-60/p/197662415/category=0

About Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and non-cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC. 

“Andy Jagpal” 

President and Director 

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected] 

To learn more about what this news means to the shareholders visit: 

Shop: www.primoceuticals.com 

www.twitter.com/prmonutra 

https://t.me/PrimoNutraceuticals

www.thrivecbd.org 

www.beautykitchen.net 

www.drinkdefy.com 

Corporate: www.primonutraceuticals.com 

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. No regulatory authority has approved or disapproved the information contained in this news release.

New Age Metals $NAM.ca River Valley Drilling Continues to Intersect and Expand #Palladium Mineralization at the Pine Zone $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN #PGM

Posted by AGORACOM-JC at 9:13 AM on Tuesday, June 2nd, 2020
  • Palladium mineralization is still open to expansion by drilling to the east, particularly testing a strong IP chargeability high located about 400 metres along strike, and also by drilling down-dip to the south
  • Hole PZ-20-04 intersected 1101 ppb Pd+Pt+Au (1.250 g/t PdEq) over 12 metres from 50 metres downhole, including 1361 ppb Pd+Pt+Au over 8 metres in the Pine Zone; and
  • Hole PZ-20-01 intersects 1287 ppb Pd+Pt+Au (1.477 g/t PdEq) over 3 metres from 168 metres downhole in the Pine Zone

June 2nd, 2020 – Rockport, Canada – New Age Metals Inc. (TSXV:NAM); (OTC:NMTLF); (FSE:P7J) – The Company is pleased to announce new results from the 2020 Phase 1 exploration drilling program at its 100% owned River Valley Palladium Project. This district-scale land package and large mineral resource is located near the City of Sudbury, Ontario,
and its world-class mining and processing facilities.

Chairman and CEO Harry Barr stated; “Phase 1 of the 2020 drill program was successful in extending the known limits of the Pine Zone Palladium mineralization 50 metres up-dip to the north and 50 metres along strike to the east. The Palladium mineralization is still open to expansion by drilling to the east, particularly testing a strong IP chargeability high located about 400 metres along strike, and also by drilling down-dip to the south (see Figure 1). The 2020 drilling was also successful at broadly establishing the presence of Palladium mineralization at the connection of the Pine Zone to the Dana North Zone.”

This release describes results from 1,685.5 metres of drilling in 8 holes completed in Q2 2020 on the Pine Zone-Dana North Zone area of the multi-million-ounce River Valley Palladium Project. The objectives of the drill program were threefold: 1) expand the limits of the Pine Zone Palladium mineralization; 2) investigate possible connection of the Pine Zone to the Dana North Zone at depth; and 3) test Palladium mineralization continuity within the 2019 Block Model.
The drill program was successful in extending the Pine Zone mineralization up-dip to the north and along strike to the east, thereby demonstrating opportunity to further expand the Mineral Resources in support of a Prefeasibility Study in 2021-2022.

The Pine Zone was discovered by drilling an IP chargeability high in 2015-2016, in the footwall to the main River Valley deposit at the Dana North Zone, at the north end of the Property and under the main access road. Seven holes were drilled into the Pine Zone-T3 area in 2015-2016 and 14 in 2017 plus the 5 in 2020 for a total of 26 holes. Before 2015, seven holes had been drilled through the Dana North Zone and into the Pine Zone prior to recognition of the latter as a separate, differently oriented zone.

2020 Palladium Highlights

Highlights of the Phase 1 2020 drill program are as follows:

– Hole PZ-20-04 intersected 1101 ppb Pd+Pt+Au (1.250 g/t PdEq) over 12 metres from 50 metres downhole, including 1361 ppb Pd+Pt+Au over 8 metres in the Pine Zone; and

– Hole PZ-20-01 intersects 1287 ppb Pd+Pt+Au (1.477 g/t PdEq) over 3 metres from 168 metres downhole in the Pine Zone

Palladium Results

The details of the Phase 1 2020 drill program are presented in Tables 1-2 and Figure 1.
Holes PZ-20-02 and PZ-20-04, -05 and -06 were drilled to expand the Palladium mineralization beyond the 2019 Mineral Resources at the Pine Zone. Hole PZ-20-02 targeted an IP chargeability high and intersected 0.597 g/t PdEq from 125 metres downhole, which expands the mineralization 50 metres along strike to the east from the Mineral Resource Block Model. Holes PZ-20-04, -05 and -06 were drilled to expand the Palladium mineralization up-dip to the north, by 10 metres,
50 metres and 100 metres, respectively. Hole PZ-20-04 targeted an IP chargeability high and intersected 12 metres grading 1.250 g/t PdEq from only 50 metres downhole, including
8 metres at 1.542 g/t PdEq
, and 5 metres grading 0.499 g/t PdEq from 66 metres downhole.
Hole PZ-20-05 intersected 3 metres grading 0.857 g/t PdEq from only 50 metres downhole.
This intersection appears to be slightly more copper rich (Table 2). Hole PZ-20-06 lacked significant assay results but did intersect the breccia unit, the favourable host rock for the Palladium mineralization at River Valley.

Holes T3-20-01, T3-20-02 and PZ-20-03 were drilled to test for the presence of Palladium mineralization where the Pine Zone may be connected at depth to the main River Valley Palladium deposit at the Dana North Zone. Palladium mineralization was intersected in all three holes:
1) Hole T3-20-01 intersected 17 metres grading 0.744 g/t PdEq from 248 metres downhole;
2) T3-20-02 intersected 17 metres of 0.622 g/t PdEq from 318 metres downhole; and 3) PZ-20-03 intersected 0.412 g/t PdEq from 197 metres downhole.

Hole PZ-20-01 was designed to test Palladium grade continuity within the 2019 Mineral Resource Model. PZ-20-01 was collared 50 metres from the nearest previously drilled hole and intersected 3 metres grading 1.477 g/t PdEq from 168 metres downhole. This intersection lies within the Block Model volume of the 2019 mineral resource.


Click Image To View Full Size

* Collar coordinates are UTM NAD83 Zone 17N


Click Image To View Full Size

Notes: 1000 ppb = 1 gram/tonne

The lengths reported are core lengths, but should approximate true widths

nsa = no significant assays

PdEq g/t = Pd g/t + (Pt g/t x 0.89) + (Au g/t x 1.20) + (Cu% x 1.34) + (Ni% x 2.55) + (Co% x 9.01)

For PdEq calculation details, see 2019 Technical Report, “Updated Mineral Resource Estimate and Preliminary Economic Assessment of the River Valley Project”, by P&E Mining Consultants Inc. and DRA Americas Inc.


Click Image To View Full Size

Figure 1. Location of 2020 Phase 1 drill holes (labelled) and previously drilled holes plotted on an inverted IP chargeability image (coloured) and 3-D wireframe model of the Dana North Zone and Pine Zone (covered), River Valley Palladium Project near Sudbury (Ontario, Canada). Note from the inset map that the River Valley Palladium Project is located 60 linear km ENE of the City of Sudbury.

Discussion

The Palladium mineralization at the Pine Zone remains open to expansion by drilling to the east, particularly testing a strong IP chargeability high located about 400 metres along strike, and also by drilling down-dip to the south. Palladium mineralization was also broadly established at the connection of the Pine Zone to the Dana North Zone.

The results of the 2020 Phase 1 drilling bring the cumulative total number of holes intersecting the Pine Zone to 33. The number of Palladium mineralized intersections within the Pine Zone now totals 41, over an area measuring up to 250 metres along strike and 550 metres down-dip.
Note again that the Pine Zone remains open down-dip and particularly to the east, where the most tantalizing IP chargeability high is located.

Assay Procedures & QA/QC

The 2020 Phase 1 drilling was completed by Jacob & Samuel Drilling Ltd. of Sudbury, Ontario under the supervision of NAM geologists. The drill core samples were sent to the SGS Canada Inc. Laboratory in Lakefield, Ontario for sample preparation and assay analyses. The preparation involved crushing of 3 kg of each sample to 90% passing 2 mm, and then pulverizing 0.5 kg to 85% passing 75 um. Palladium, Platinum and Gold were assayed by fire assay with ICP-AES finish (GE-FAI313). Copper, Nickel and 32 additional metals were assayed by two acid digestion and ICP-OES finish (GE-ICP14B). Blanks and blind certified standard samples were submitted at regular intervals for assay with the core samples as part of NAM’s rigorous Quality Assurance/Quality Control program.

Next Steps

NAM is considering its next steps in Palladium exploration and project development at River Valley in 2020. The next steps include any one or a combination of the following activities:

– Analyze significant Palladium core intersections in the Pine Zone for Rhodium;

– Update the 3-D geological modelling of the Pine Zone;

– Carry out further environmental baseline studies (including an archaeological survey);

– Complete Phase 2 drilling, particularly at the priority footwall IP chargeability high,

the Pine Zone-Dana North Zone connection, and down-dip;

– Conduct borehole-IP surveys for off-hole anomalies outside the known resource; and

– Undertake Phase 2 metallurgical studies

The purpose of these activities would be to advance the River Valley Palladium Project and support the Prefeasibility study planned for 2021-22.

About the River Valley Palladium Project

The details of the updated Mineral Resource Estimate (MRE) and Preliminary Economic Assessment (PEA) were announced in the press release dated August 9, 2019 and are described on NAM’s website. The pit constrained Updated Mineral Resource Estimate formed the basis of the PEA. At a cut-off grade of 0.35 g/t PdEq, the Updated Mineral Resource Estimate contains 2.867 Moz PdEq in the Measured plus Indicated classifications and 1.059 Moz PdEq in the Inferred classification. The PEA is a preliminary report, but it demonstrates that there are potentially positive economics for a large-scale mining open pit operation, with 14 years of Palladium production. Refer to the NAM website (www.newagemetals.com) for details.

About NAM

New Age Metals is a junior mineral exploration and development company focused on the discovery, exploration and development of green metal projects in North America.
The Company has two divisions; a Platinum Group Metals division and a Lithium/Rare Element division. The PGM division includes the 100% owned River Valley Project, one of North America’s largest undeveloped Platinum Group Metals Projects, situated 100 km from Sudbury, Ontario and the Genesis PGM Project in Alaska. The Lithium division is the largest mineral claim holder in the Winnipeg River Pegmatite Field where the Company is exploring for hard rock lithium and various rare elements such as tantalum and rubidium. Our philosophy is to be a project generator with the objective of optioning our projects with major and junior mining companies through to production. New Age Metals is a junior resource company on the TSX Venture Exchange, trading symbol NAM, OTCQB: NMTLF; FSE: P7J with 137,347,966 shares issued to date.

Investors are invited to visit the New Age Metals website at www.newagemetals.com where they can review the company and its corporate activities. Any questions or comments can be directed to [email protected] or Harry Barr at [email protected] or Cody Hunt at [email protected] or call 613 659 2773.

Opt-in List

If you have not done so already, we encourage you to sign up on our website (www.newagemetals.com) to receive our updated news.

Qualified Person

The contents contained herein that relate to Exploration Results or Mineral Resources is based on information compiled, reviewed or prepared by Bill Stone, P.Geo., a consulting geoscientist for New Age Metals. Dr. Stone is the Qualified Person as defined by National Instrument 43-101 and has reviewed and approved the technical content of this news release.

On behalf of the Board of Directors

Harry Barr”

Harry G. Barr

Chairman and CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results and are based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions. These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR (www.sedar.com), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors should not place undue reliance on forward-looking statements.

MedX Health $MDX.ca Joins AGORACOM Platform For Online Marketing And Verified Discussion Forum For Clean Social Media Engagement With Investors

Posted by AGORACOM-JC at 9:08 PM on Monday, June 1st, 2020
MedX Health Corp. (TSXV: MDX) | LinkedIn
  • Announced the launch of a 12 month online marketing campaign through AGORACOM for the purposes of targeting new potential investors that would be specifically interested in the Company’s primary sectors
  • MedX has also launched “CEO Verified” Discussion Forum on AGORACOM to serve as the Company’s primary social media platform to interact with both current and prospective shareholders in a fully moderated environment

TORONTO, JUNE 1, 2020 —  MedX Health Corp. (“MedX” or the “Company”) (MDX:TSXV), a leading medical device and software company focused on skin cancer detection and telemedicine diagnosis, is pleased to announce the launch of a 12 month online marketing campaign through AGORACOM for the purposes of targeting new potential investors that would be specifically interested in the Company’s primary sectors.  MedX is paying $0 in cash for the program thanks to AGORACOM’s cashless and fully compliant shares for services program.      

SIGNIFICANT EXPOSURE THROUGH AGORACOM DIGITAL NETWORK 

In 2019, AGORACOM surpassed 600 million page views, exceeded industry engagement metrics by over 400% and has served over 350 public companies. 

The MedX HUB containing multiple landing pages, videos, photos and other helpful information updated in real-time over the next 12 months can be found at https://agoracom.com/ir/MDX.   

The MedX HUB will receive significant exposure through continuous brand impression, content marketing, search engine marketing and social media engagement throughout the entire AGORACOM network.  AGORACOM is the only small cap marketing firm to hold a Twitter Verified badge, averaging 4.2 million Twitter impressions per month in 2019. 

MODERATED DISCUSSION FOR MEDX MANAGEMENT AND SHAREHOLDERS 

MedX has also launched “CEO Verified” Discussion Forum on AGORACOM to serve as the Company’s primary social media platform to interact with both current and prospective shareholders in a fully moderated environment. 

AGORACOM “CEO Verified” forums provide the small cap industry’s first ever identity verification of company executives on an investor platform.  For the first time ever, small cap CEO’s and officers can post within a discussion forum without the risk of impersonation.  As the ultimate influencers of their own companies, “CEO Verified” Forums create unmatched levels of engagement between management and investors that create civilized, constructive and factual conversation. 

The MedX Forum can be found at https://agoracom.com/ir/MDX/forums/discussion 

VERIFIED MEDX OFFICER AT LAUNCH 

·         Mike Druhan, VP Corporate Development 

Scott Spean, Chief Executive Officer & President stated, “After receiving the largest order in Company history from our Brazilian distributor earlier this year, it became clear to us the time had arrived to finally start raising our brand awareness amongst small cap investors all over North America.  We expect 2020 to be our commercial breakout year and AGORACOM came highly recommended as the firm best capable of accomplishing this goal. As we build our audience of new investors in 2020, I encourage our long-time and loyal shareholders to read and participate in our new CEO Verified Discussion Forum to create great, vibrant and constructive discussion for the long term benefit of everyone. ” 

George Tsiolis, AGORACOM Founder stated “Fans of AGORACOM know very well that 3rd party validation is a very important element of our decision to take on a client. MedX’s success in Brazil this year, as well as, $3,100,000 raised during the most challenging environment in modern history serves as significant evidence of the Company’s strength.  The additional and more important benefit of knowing we will help save lives of thousands of investors in the future was just too great to give up.  We are happy to take their story to the world and encourage shareholders to do the same by participating and sharing the HUB with their networks.” 

SHARES FOR SERVICES 

The Company intends to issue common shares in the capital of the Company to AGORA in exchange for the Services.  Pursuant to the terms of the Agreement, the Company will be issuing a total fee of $60,000 (plus HST), to be paid as follows:  

TERM:                        May 11, 2020 – May 30, 2021 

  • $12,000 + HST Shares For Services upon Commencement May 11, 2020 for initial set up of HUB, marketing materials and search engine programs.
  • $12,000 + HST Shares For Services at end of Third Month August 11, 2020
  • $12,000 + HST Shares For Services at end of Sixth Month November1 1, 2020
  • $12,000 + HST Shares For Services at end of Ninth Month February 11, 2021
  • $12,000 + HST Shares For Services at end of Twelfth Month May 30, 2021

Per TSX Venture Policy 4.3 (Section 6.1), the deemed price of the securities to be issued will be determined after the date services are provided to advertiser in each period and are to be calculated using the closing price on each date above.

About AGORACOM 

AGORACOM is the pioneer of online marketing, broadcasting, conferences and investor relations services to North American small and mid-cap public companies, with more than 300 companies served. AGORACOM is the home of more than 7.7 million investors that visited 55.2 million times and read over 600 million pages of information over the last 10 years. The average visit of 8min 43sec is more than double that of global financial sites, which can be attributed to the implementation and enforcement of the strongest moderation rules in the industry.

ABOUT MEDX HEALTH CORP.

MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin cancer with its SIAscopy on DermSecure™ telemedicine platform, utilizing its SIAscopy™ technology. SIAscopy™ is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA (US), ARTG and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com.

This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of applicable Canadian securities legislation. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company’s limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company’s projections or forward-looking statements. All forward looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Scott Spearn, President and CEO
MedX Health Corp
905-670-4428 ext 229 

CLIENT FEATURE: Else Nutrition $BABY.ca The Award Winning, Plant-Based Nutrition Company For Small Cap Investors $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 3:53 PM on Thursday, May 28th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Highlights

  • $CAD 10 million cash and runway for well over a year;
  • Backed By A Billion Dollar Global Nutrition Company;
  • MOU For International Distribution Of Products
  • US Product Launch Planned For Q3-2020;
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • Executives & Advisors From Globally Renowned Companies & Institutions

Here’s What The Experts Say

“Finally a high quality, nutritionally-dense, tasty, plant-based alternative that is low in sugar.  Else is filling a much needed gap, and providing an alternative for those looking to avoid dairy or soy, and a viable option for intolerances and other diet considerations.”

Nicole Silber, RD, CSP, CLC

Else Nutrition Holdings is an advertising client of AGORA Internet Relations Corp.

Hollister $HOLL.ca Launches Tommy Chong’s Cannabis 1:1 Full-Spectrum Elixir $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 11:06 AM on Wednesday, May 27th, 2020
  • Announced the tincture it is manufacturing and distributing for its partner, Tommy Chong’s Cannabis, is officially ready to hit the market
  • The tincture, branded Tommy Chong’s Cannabis™ 1:1 Full Spectrum Elixir, features a sweet berry flavor and 1:1 ratio of CBD to THC; for a total of 1000mg cannabinoids (500mg CBD and 500mg THC).
  • Tommy Chong’s Cannabis™ Full Spectrum Elixir 1:1, is being distributed exclusively by Hollister Cannabis Co.’s distribution partner, Indus Holdings, Inc. (CSE: INDS)

VANCOUVER, May 27, 2020 - Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister“) – a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to announce the tincture it is manufacturing and distributing for its partner, Tommy Chong’s Cannabis, is officially ready to hit the market.

The tincture, branded Tommy Chong’s Cannabis™ 1:1 Full Spectrum Elixir, features a sweet berry flavor and 1:1 ratio of CBD to THC; for a total of 1000mg cannabinoids (500mg CBD and 500mg THC). True to the manufacturing mission of Hollister Cannabis Co., this 1:1 tincture was crafted in small, artisanal batches for optimal quality and made from premium California-grown cannabis. 

The tincture, Tommy Chong’s Cannabis™ Full Spectrum Elixir 1:1, is being distributed exclusively by Hollister Cannabis Co.’s distribution partner, Indus Holdings, Inc. (CSE: INDS)

CEO of Hollister Biosciences, Carl Saling, shared: “We are thrilled to have Tommy Chong’s Full Spectrum Elixir at Indus’ distribution center, ready to distribute to dispensaries in California. I am super proud of our team – especially through this global pandemic. We have continued to push forward and release a legendary product for a true legend!”

About Tommy Chong’s Cannabis: 

As one-half of the legendary comedy duo Cheech & Chong, Tommy Chong helped pioneer a completely unique brand of comedy directed at the counterculture movement of the early ’70s. At the heart of this brand of entertainment was cannabis. On-screen and off Tommy became a vocal advocate for his favorite herb. In a time where cannabis had to be talked about in whispers, Tommy was a loud voice for the advocacy movement, working tirelessly to destigmatize the use of this healing plant. With the legalization of recreational cannabis, Tommy’s voice continues to ring out loudly, touting its benefits and place in society. Now, Tommy is thrilled to share that passion and knowledge of cannabis with the rest of the world. Using his lifelong connections in the industry, he has made it his personal mission to share the very best product available with his fans and fellow herb connoisseurs. If anyone knows weed, it’s Tommy. And now fans of comedy and cannabis alike can experience the strains and products that Tommy himself has hand-selected.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.  Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

ON BEHALF OF THE BOARD

“Carl Saling”

CEO and Director

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

PyroGenesis $PYR.ca Increases Stake in HPQ Silicon $HPQ.ca $FSLR $SPWR $CSIQ $XMG.ca

Posted by AGORACOM-JC at 11:07 AM on Tuesday, May 26th, 2020

– Directors of the Corporation have agreed to settle an outstanding debt for services rendered by PyroGenesis Canada Inc, (TSX-V: PYR) in connection with works relating to leasehold improvements done in the dedicated PUREVAPTM Quartz Reduction Reactor (“QRR”) premises within PyroGenesis production plant.

MONTREAL, May 26, 2020 — HPQ Silicon Resources Inc.  (“HPQ” or the “Company”) TSX-V: HPQ; FWB: UGE; Other OTC : URAGF; would like inform shareholders that the Directors of the Corporation have agreed to settle an outstanding debt for services rendered by PyroGenesis Canada Inc, (TSX-V: PYR) in connection with works relating to leasehold improvements done in the dedicated PUREVAPTM Quartz Reduction Reactor (“QRR”) premises within PyroGenesis production plant.

The outstanding debt of $395,514, will be settled by issuing 4,394,600 Units at a price of $0.09 per unit. Each unit is comprised of one common share and one common share purchase warrant.  Each warrant will allow its holder to subscribe to one common share at the price of $0.10 for a period of 36 months from the date of closing.  Each share issued pursuant to the debt settlement will have a mandatory four (4) month and one (1) day holding period from the date of closing.  This settlement is subject to the approval of the TSX Venture Exchange.

“This transaction is a demonstration of the strong cooperation HPQ and PyroGenesis are implementing as we develop both the PUREVAPTM Quartz Reduction Reactor (QRR) and the PUREVAPTM Silicon Nano Reactor (SiNR) processes,” said Bernard Tourillon, President & CEO of HPQ Silicon.  “Our PUREVAPTM processes opens up unique multibillion-dollar business opportunity for HPQ and PyroGenesis, as we strive to deliver the critical Silicon nano- materials required by the surging Li-ion battery market.”

About Silicon

Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RER”) presently under way. Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a capital and energy intensive process.

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is a producer of Silicon Innovation that is building a portfolio of unique high value silicon products needed for the RER.

Working with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAPTM “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential;
    • HPQ is in the process of becoming the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon (3N – 4N Si);
  • The PUREVAPTM Silicon Nano Reactor (SiNR), a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;
    • HPQ objective is to become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries;
    • During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using the newly develop PUREVAPTM SiNR process.

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;
    • The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries.
    • The plan is to deliver porous Si wafer to a battery manufacturer (under NDA) for testing in 2020.

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders. 

Disclaimers:

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or the securities laws of any state of the United States and may not be offered or sold within the United States or to, or for the account or the benefit of, U.S. persons (as defined in Regulation S under the U.S.  Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected] 

Primo Nutraceuticals $PRMO.ca Receives NPN (Natural Product Number) from Health Canada $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 4:42 PM on Friday, May 22nd, 2020

– Received its NPN (Natural Product Number) from Health Canada.

– Primo Nutraceuticals hand sanitizers meet Health Canada’s requirements for safety, effectiveness and quality.

– In response to the increasing demand for hand sanitizers in Canada during the current COVID-19 pandemic, Health Canada has implemented an interim expedited licensing approach to help businesses like Primo to obtain the required authorizations to produce and distribute hand sanitizer.

VANCOUVER, British Columbia, May 22, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has received its NPN (Natural Product Number) from Health Canada. Primo Nutraceuticals hand sanitizers meet Health Canada’s requirements for safety, effectiveness and quality.

In response to the increasing demand for hand sanitizers in Canada during the current COVID-19 pandemic, Health Canada has implemented an interim expedited licensing approach to help businesses like Primo to obtain the required authorizations to produce and distribute hand sanitizer. Consistent with the interim measure for alcohol-based hand sanitizers currently in place, Primo’s hand sanitizer can be distributed to healthcare and commercial settings across Canada.

The Natural Product Number NPN 80099466 issued to Primo will be located on every Primo product label distributed.

The Natural Product Number contains information about the natural health product and found to be safe, effective and of high quality under their recommended conditions of use. You can identify licensed natural health products by looking for the eight-digit Natural Product Number (NPN) or Homeopathic Medicine Number (DIN-HM) on the label.

Sales are to commence in June 2020. No purchase orders are yet in place.

To view the product brochure visit: https://www.primoceuticals.com/shop#!/Primo-Lemon-Hand-Sanitizer-60/p/197662415/category=0

About Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and non-cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

“Andy Jagpal”

President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected]

To learn more about what this news means to the shareholders visit:

https://t.me/PrimoNutraceuticals

Shop: www.primoceuticals.com

www.twitter.com/prmonutra

www.thrivecbd.org

www.beautykitchen.net

www.marianna.ca

www.drinkdefy.com

Corporate: www.primonutraceuticals.com

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. No regulatory authority has approved or disapproved the information contained in this news release.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c8349cf6-4f9e-49b2-9769-53f0c3274f0d

Primo Hand Sanitizer
Primo Nutraceuticals hand sanitizers meet Health Canada’s requirements for safety, effectiveness and quality.

Else Nutrition $BABY.ca Provides Corporate Update – Product Launch In U.S. Expected In Q3 $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 10:41 AM on Friday, May 22nd, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Engagement with Covet PR ahead of planned product launch in the U.S.; Covet specializes in alternative foods promotion with clients such as Beyond Meat, Banza, Kashi, Once Upon a Farm, and many others
  • Positive social campaign testing results, reached over 320,000 potential customers in the U.S.
  • Partnership with “Mom’s Meet”, a community of approximately 100,000 U.S. moms dedicated to exploring new children products
  • Product launch in the U.S. expected in late July or early August 2020 (4-8 week delay from original pre-July launch date due to Covid 19)
  • Toddler Nutrition product sampling campaign planned to launch on June 15, 2020

VANCOUVER, BC / May 22, 2020 / ELSE NUTRITION HOLDINGS INC. (TSX-V:BABY) (OTCQB:BABYF) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition, is pleased to provide the following corporate update.

Marketing for Upcoming Product Launch

Else is pleased to announce that it has engaged Covet PR, a national U.S.-based public relations firm devoted to food, beverage, beauty and lifestyle brands. Covet will) support the launch of Else products into the U.S. marketplace in Q3-2020. Covet’s client roster includes impressive, disruptive and leading wellness brands, such as: Beyond Meat, Banza, Kashi, Once Upon a Farm, and many other better-for-you consumer product companies.

“As experts in the plant-based nutrition space, we are thrilled to be partnering with Else Nutrition for their U.S. launch,” says Sara Brooks, Founder, and CEO of Covet PR. “At Covet PR, we are passionate about companies that are truly innovating, making this world a healthier and happier place. Furthermore, as a mom of two young children, I am equally as excited about having a better, complete nutrition solution I can depend on, and I look forward to sharing this brand with consumers nationwide.”

During the month of April, Else executed its first paid test campaigns on social media platforms, showing highly promising results and customer engagement. The brand was exposed to over 320,000 potential U.S. customers, with more than double the industry average clickthrough rate. The clickthrough rate is a widely accepted industry standard indicator of high customer interest in the brand. Insights gleaned from this campaign will be integrated into a sampling campaign planned to launch on June 15th 2020, when customers will be able to order Else Toddler Nutrition samples.

The Company has also partnered with Mom’s Meet, a dedicated community of approximately 100,000 U.S. moms exploring new consumer products for their children. The program will raise brand awareness among this group via digital communications, and will drive sampling for Else Plant-Based Toddler Nutrition.

Product Launch Date

Management is pleased to announce that the impact of the COVID-19 pandemic, on Company’s business was minimal, causing an approximate 2 month delay in product launch which is currently scheduled for late July or early August 2020. Else also expects to finalize its agreement with a leading U.S.-based organic baby formula manufacturer for the production of its plant-based toddler nutrition product in June of 2020.

About Else Nutrition Holdings Inc.

Else Nutrition GH ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, 100% plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition won the “2017 Best Health and Diet Solutions’ award at the Global Food Innovation Summit in Milan. The holding company, ELSE Nutrition Holdings Inc, is a publicly-traded company, listed as TSX-V: BABY, as part of the TSX Venture Exchange and as OTCQB: BABYF as part of the NY OTC QB Exchange. Else’s Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children’s Hospital, ESPHGAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition). Plum Organics, Tel Aviv University’s Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)52-447-9931

Mr. Sokhie Puar, Director of Else Nutrition
Email: [email protected]
Telephone: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that, to the extent they are not recitations of historical fact, constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “plan”, “hope to”, “intend” or similar expressions. Forward-looking statements in this press release include, but are not limited to, statements with respect to: the Company’s commercialization of its products and expected timing, expected go-to-market strategy (including marketing, proposed markets, sales, customer growth and market position), and industry conditions including any impact of Covid-19. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the successful completion of Else’s proposed scale-up for its products, restrictions due to Covid-19 will not result in additional unplanned delays, and such statements are intended to apply only to the infant formula market for ages 12 months and above, and having all necessary regulatory approval as required by each target market. Numerous risks and uncertainties could cause the Company’s actual results to differ materially from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements, including, but not limited to: consumer demand for the Company’s products, whether the Company’s current and future products achieve commercialization, uncertainty regarding material changes in laws and regulations, retention of key personnel, the Company’s ability to expand into global markets and competitive developments, and the impact of Covid-19 on the planned business operations. The foregoing list of factors is not exhaustive, and other risks and uncertainties not presently known, or believed to be material, to management Additional information and other factors that could affect the operations or financial results of the Company are set out in the Company’s Filing Statement dated May 14, 2019 under the heading “Risk Factors” and may be accessed through the SEDAR website (www.sedar.com). Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law

New Age Metals $NAM.ca Appoints Mr. Cody Hunt as VP Business Development $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN #PGM

Posted by AGORACOM-JC at 8:39 AM on Thursday, May 21st, 2020

May 21st, 2020 – Vancouver, Canada – New Age Metals Inc. (TSXV:NAM); (OTC:NMTLF); (FSE:P7J). The Company is pleased to appoint Mr. Cody Hunt as Vice President of Business Development.

Chairman and CEO Harry Barr stated; “Over the past two years, Mr. Hunt has done an excellent job working in all aspects of business development for New Age Metals. The board and management of New Age Metals are pleased to promote Mr. Hunt to an officer of the Company with his title of Vice President of Business Development. Going forward, Mr. Hunt will work with the board and management to find new strategic partners for the Company’s projects, participate in and monitor the technical development of our existing projects, evaluate potential new opportunities and continue to source additional funding for the Company.”

Mr. Hunt has worked for New Age since 2018 in Business Development and has been actively involved in identifying, establishing and developing strategic relationships and has participated in the development and execution of the company’s business planning and strategy. Mr. Hunt is a graduate of Queen’s University from the Robert M. Buchan Department of Mining. He received his Bachelors degree in Mining Engineering while specializing in Mineral Processing in 2018. Mr. Hunt is also actively pursuing his Chartered Financial Analyst designation.

About NAM

New Age Metals is a junior mineral exploration and development company focused on the discovery, exploration and development of green metal projects in North America. The Company has two divisions; a Platinum Group Metals division and a Lithium/Rare Element division. The PGM division includes the 100% owned River Valley Project, one of North America’s largest undeveloped Platinum Group Metals Projects, situated 100 kilometers from Sudbury, Ontario as well as the Genesis PGM Project in Alaska. The Lithium division is the largest mineral claim holder in the Winnipeg River Pegmatite Field where the Company is exploring for hard rock lithium and various rare elements such as tantalum and rubidium. Our philosophy is to be a project generator with the objective of optioning our projects with major and junior mining companies through to production. New Age Metals is a junior resource company on the TSX Venture Exchange, trading symbol NAM, OTCQB:NMTLF; FSE:P7J with 137,347,966 shares issued to date.

Investors are invited to visit the New Age Metals website at www.newagemetals.com where they can review the company and its corporate activities. Any questions or comments can be directed to [email protected] or Harry Barr at [email protected] or Cody Hunt at [email protected] or call 613 659 2773.

Opt-in List

If you have not done so already, we encourage you to sign up on our website (www.newagemetals.com) to receive our updated news.

On behalf of the Board of Directors

Harry Barr”

Harry G. Barr

Chairman and CEO